title: Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study.
authors.affiliation: Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
authors.forename: Tadaaki
authors.identifier: http://orcid.org/0000-0003-2606-4208
authors.initials: T
authors.lastname: Nishikawa
authors.affiliation: Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan. koseih@saitama-med.ac.jp.
authors.forename: Kosei
authors.identifier: http://orcid.org/0000-0002-1903-7001
authors.initials: K
authors.lastname: Hasegawa
authors.affiliation: Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
authors.forename: Akira
authors.identifier: http://orcid.org/0000-0002-1221-0609
authors.initials: A
authors.lastname: Yabuno
authors.affiliation: Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
authors.forename: Hiroyuki
authors.identifier: http://orcid.org/0000-0002-0618-3800
authors.initials: H
authors.lastname: Yoshida
authors.affiliation: Department of Pathology, Saitama Medical University International Medical Center, Saitama, Japan.
authors.forename: Masanori
authors.identifier: http://orcid.org/0000-0002-0769-360X
authors.initials: M
authors.lastname: Yasuda
authors.affiliation: Department of Diagnostic Radiology, Saitama Medical University International Medical Center, Saitama, Japan.
authors.forename: Eito
authors.identifier: http://orcid.org/0000-0002-4260-4668
authors.initials: E
authors.lastname: Kozawa
authors.affiliation: Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
authors.forename: Keiichi
authors.identifier: http://orcid.org/0000-0002-7388-0243
authors.initials: K
authors.lastname: Fujiwara
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002296:Carcinosarcoma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007191:Indazoles; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011743:Pyrimidines / Q000008:administration & dosage* / Q000009:adverse effects; D013449:Sulfonamides / Q000008:administration & dosage* / Q000009:adverse effects; D014057:Tomography, X-Ray Computed; D014594:Uterine Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib